SAN DIEGO & ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year ...
Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
LONDON--(BUSINESS WIRE)--The global vascular embolization devices market is expected to grow by USD 1 billion during 2020-2024, progressing at a CAGR of almost 6% during the forecast period. The ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boston Scientific announced it received FDA 510(k) ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's (MDT.N), opens new tab embolization device as "most serious", following reports of the deaths ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Okami Medical has raised $45 million to commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results